WIPO Japan India China USA
[更多]
This can be seen in the patent file
[更多]
Suramab is the brand name of a new combination of drugs made up of suramin and bevacizumab. Suramab has antiangiogenic properties that can be applied to oncological and ophthalmological diseases.The european patent (EP 2186529 B1) was granted in March 2012. The US patent is still pendingThis can be .....
[更多]
|<首頁 <-上一頁 下一頁-> 末頁>| |